BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2269328)

  • 1. Processing without proteolytic cleavage is required for recognition of insulin by T cells.
    Gradehandt G; Hampl J; Milbradt S; Rüde E
    Eur J Immunol; 1990 Dec; 20(12):2637-41. PubMed ID: 2269328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endo/lysosomal protease cathepsin B is able to process conalbumin fragments for presentation to T cells.
    Gradehandt G; Ruede E
    Immunology; 1991 Nov; 74(3):393-8. PubMed ID: 1769688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin.
    Diment S
    J Immunol; 1990 Jul; 145(2):417-22. PubMed ID: 1694878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weak base amines can inhibit class I MHC-restricted antigen presentation.
    Michalek MT; Benacerraf B; Rock KL
    J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors.
    Vidard L; Rock KL; Benacerraf B
    J Immunol; 1991 Sep; 147(6):1786-91. PubMed ID: 1890304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro processing of insulin for recognition by murine T cells results in the generation of A chains with free CysSH.
    Hampl J; Gradehandt G; Kalbacher H; Rüde E
    J Immunol; 1992 May; 148(9):2664-71. PubMed ID: 1573264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.
    Semple JW; Ellis J; Delovitch TL
    J Immunol; 1989 Jun; 142(12):4184-93. PubMed ID: 2656861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin.
    Rodriguez GM; Diment S
    Eur J Immunol; 1995 Jul; 25(7):1823-7. PubMed ID: 7621859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
    Gradehandt G; Kleber N; Mattner F; Milbradt S; Rüde E
    Immunology; 1993 Apr; 78(4):592-9. PubMed ID: 8495978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of the requirement for antigen processing of pigeon cytochrome c prior to T cell activation.
    Kovac Z; Schwartz RH
    J Immunol; 1985 May; 134(5):3233-40. PubMed ID: 2580020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cathepsin D in antigen presentation of ovalbumin.
    Rodriguez GM; Diment S
    J Immunol; 1992 Nov; 149(9):2894-8. PubMed ID: 1328388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing.
    Del Pozo V; De Andrés B; Martín E; Cárdaba B; Fernández JC; Gallardo S; Tramón P; Leyva-Cobian F; Palomino P; Lahoz C
    Eur J Immunol; 1992 Jul; 22(7):1919-25. PubMed ID: 1623930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
    Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
    Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of antigen processing to the recognition of a synthetic peptide antigen by specific T cell hybridomas.
    Boyer M; Novak Z; Fotedar A; Singh B
    J Mol Recognit; 1988 Apr; 1(2):99-106. PubMed ID: 3152567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor.
    Nalefski EA; Rao A
    J Immunol; 1993 May; 150(9):3806-16. PubMed ID: 7682584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing requirements for the recognition of insulin fragments by murine T cells.
    Gradehandt G; Hampl J; Plachov D; Reske K; Rüde E
    Immunol Rev; 1988 Dec; 106():59-75. PubMed ID: 2473028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases.
    Vidard L; Rock KL; Benacerraf B
    J Immunol; 1992 Jul; 149(2):498-504. PubMed ID: 1378066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.